Cross-regulation of viral kinases with cyclin A secures shutoff of host DNA synthesis.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
24 09 2020
Historique:
received: 17 12 2019
accepted: 24 08 2020
entrez: 25 9 2020
pubmed: 26 9 2020
medline: 21 10 2020
Statut: epublish

Résumé

Herpesviruses encode conserved protein kinases (CHPKs) to stimulate phosphorylation-sensitive processes during infection. How CHPKs bind to cellular factors and how this impacts their regulatory functions is poorly understood. Here, we use quantitative proteomics to determine cellular interaction partners of human herpesvirus (HHV) CHPKs. We find that CHPKs can target key regulators of transcription and replication. The interaction with Cyclin A and associated factors is identified as a signature of β-herpesvirus kinases. Cyclin A is recruited via RXL motifs that overlap with nuclear localization signals (NLS) in the non-catalytic N termini. This architecture is conserved in HHV6, HHV7 and rodent cytomegaloviruses. Cyclin A binding competes with NLS function, enabling dynamic changes in CHPK localization and substrate phosphorylation. The cytomegalovirus kinase M97 sequesters Cyclin A in the cytosol, which is essential for viral inhibition of cellular replication. Our data highlight a fine-tuned and physiologically important interplay between a cellular cyclin and viral kinases.

Identifiants

pubmed: 32973148
doi: 10.1038/s41467-020-18542-1
pii: 10.1038/s41467-020-18542-1
pmc: PMC7518283
doi:

Substances chimiques

Cyclin A 0
Nuclear Localization Signals 0
Viral Proteins 0
DNA 9007-49-2
Protein Kinases EC 2.7.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4845

Références

Adler, B., Sattler, C. & Adler, H. Herpesviruses and their host cells: a successful liaison. Trends Microbiol. 25, 229–241 (2017).
pubmed: 27956142 doi: 10.1016/j.tim.2016.11.009
Mocarski, E. S. Jr. in Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis Ch. 4 (eds Arvin, A. et al.) (Cambridge Univ. Press, 2011).
Gershburg, E. & Pagano, J. S. Conserved herpesvirus protein kinases. Biochim. Biophys. Acta 1784, 203–212 (2008).
pubmed: 17881303 doi: 10.1016/j.bbapap.2007.08.009
Li, R. & Hayward, S. D. Potential of protein kinase inhibitors for treating herpesvirus-associated disease. Trends Microbiol. 21, 286–295 (2013).
pubmed: 23608036 pmcid: 3674143 doi: 10.1016/j.tim.2013.03.005
Topalis, D., Gillemot, S., Snoeck, R. & Andrei, G. Thymidine kinase and protein kinase in drug-resistant herpesviruses: heads of a Lernaean Hydra. Drug Resist. Updat. 37, 1–16 (2018).
pubmed: 29548479 doi: 10.1016/j.drup.2018.01.003
Jacob, T., Van den Broeke, C. & Favoreel, H. W. Viral serine/threonine protein kinases. J. Virol. 85, 1158–1173 (2011).
pubmed: 21084474 doi: 10.1128/JVI.01369-10
Li, R. et al. Conserved herpesvirus kinases target the DNA damage response pathway and TIP60 histone acetyltransferase to promote virus replication. Cell Host Microbe 10, 390–400 (2011).
pubmed: 22018239 pmcid: 3253558 doi: 10.1016/j.chom.2011.08.013
Tarakanova, V. L. et al. Gamma-herpesvirus kinase actively initiates a DNA damage response by inducing phosphorylation of H2AX to foster viral replication. Cell Host Microbe 1, 275–286 (2007).
pubmed: 18005708 pmcid: 2034359 doi: 10.1016/j.chom.2007.05.008
Kato, K. et al. Epstein–Barr virus-encoded protein kinase BGLF4 mediates hyperphosphorylation of cellular elongation factor 1δ (EF-1δ): EF-1δ is universally modified by conserved protein kinases of herpesviruses in mammalian cells. J. Gen. Virol. 82, 1457–1463 (2001).
pubmed: 11369891 doi: 10.1099/0022-1317-82-6-1457
Hwang, S. et al. Conserved herpesviral kinase promotes viral persistence by inhibiting the IRF-3-mediated type I interferon response. Cell Host Microbe 5, 166–178 (2009).
pubmed: 19218087 pmcid: 2749518 doi: 10.1016/j.chom.2008.12.013
Kawaguchi, Y. et al. Conserved protein kinases encoded by herpesviruses and cellular protein kinase cdc2 target the same phosphorylation site in eukaryotic elongation factor 1delta. J. Virol. 77, 2359–2368 (2003).
pubmed: 12551973 pmcid: 141098 doi: 10.1128/JVI.77.4.2359-2368.2003
Oberstein, A., Perlman, D. H., Shenk, T. & Terry, L. J. Human cytomegalovirus pUL97 kinase induces global changes in the infected cell phosphoproteome. Proteomics 15, 2006–2022 (2015).
pubmed: 25867546 pmcid: 4522931 doi: 10.1002/pmic.201400607
Kuny, C. V., Chinchilla, K., Culbertson, M. R. & Kalejta, R. F. Cyclin-dependent kinase-like function is shared by the beta- and gamma- subset of the conserved herpesvirus protein kinases. PLoS Pathog. 6, e1001092 (2010).
pubmed: 20838604 pmcid: 2936540 doi: 10.1371/journal.ppat.1001092
Hamirally, S. et al. Viral mimicry of Cdc2/cyclin-dependent kinase 1 mediates disruption of nuclear lamina during human cytomegalovirus nuclear egress. PLoS Pathog. 5, e1000275 (2009).
pubmed: 19165338 pmcid: 2625439 doi: 10.1371/journal.ppat.1000275
Romaker, D. et al. Analysis of the structure–activity relationship of four herpesviral UL97 subfamily protein kinases reveals partial but not full functional conservation†. J. Med. Chem. 49, 7044–7053 (2006).
pubmed: 17125257 doi: 10.1021/jm060696s
Lee, C.-P. et al. Epstein–Barr virus BGLF4 kinase induces premature chromosome condensation through activation of condensin and topoisomerase II. J. Virol. 81, 5166–5180 (2007).
pubmed: 17360754 pmcid: 1900198 doi: 10.1128/JVI.00120-07
Hume, A. J. et al. Phosphorylation of retinoblastoma protein by viral protein with cyclin-dependent kinase function. Science 320, 797–799 (2008).
pubmed: 18467589 doi: 10.1126/science.1152095
Steingruber, M. et al. Cyclins B1, T1 and H differ in their molecular mode of interaction with cytomegalovirus protein kinase pUL97. J. Biol. Chem. 294, 6188–6203 (2019).
pubmed: 30782840 pmcid: 6463711 doi: 10.1074/jbc.RA118.007049
Prichard, M. N. et al. Human cytomegalovirus UL97 kinase activity is required for the hyperphosphorylation of retinoblastoma protein and inhibits the formation of nuclear aggresomes. J. Virol. 82, 5054–5067 (2008).
pubmed: 18321963 pmcid: 2346732 doi: 10.1128/JVI.02174-07
Zhang, K., Lv, D.-W. & Li, R. Conserved herpesvirus protein kinases target SAMHD1 to facilitate virus replication. Cell Rep. 28, 449–459.e5 (2019).
pubmed: 31291580 pmcid: 6668718 doi: 10.1016/j.celrep.2019.04.020
Businger, R. et al. Human cytomegalovirus overcomes SAMHD1 restriction in macrophages via pUL97. Nat. Microbiol. 4, 2260–2272 (2019).
pubmed: 31548682 doi: 10.1038/s41564-019-0557-8
Milbradt, J. et al. The prolyl isomerase Pin1 promotes the herpesvirus-induced phosphorylation-dependent disassembly of the nuclear lamina required for nucleocytoplasmic egress. PLoS Pathog. 12, e1005825 (2016).
pubmed: 27556400 pmcid: 4996521 doi: 10.1371/journal.ppat.1005825
Deutschmann, J. et al. A viral kinase counteracts in vivo restriction of murine cytomegalovirus by SAMHD1. Nat. Microbiol. 4, 2273–2284 (2019).
pubmed: 31548683 doi: 10.1038/s41564-019-0529-z
Iwahori, S., Hakki, M., Chou, S. & Kalejta, R. F. Molecular determinants for the inactivation of the retinoblastoma tumor suppressor by the viral cyclin-dependent kinase UL97. J. Biol. Chem. 290, 19666–19680 (2015).
pubmed: 26100623 pmcid: 4528131 doi: 10.1074/jbc.M115.660043
Li, R. et al. SUMO binding by the Epstein-Barr virus protein kinase BGLF4 is crucial for BGLF4 function. J. Virol. 86, 5412–5421 (2012).
pubmed: 22398289 pmcid: 3347263 doi: 10.1128/JVI.00314-12
Avey, D. et al. Discovery of a coregulatory interaction between Kaposi’s sarcoma-associated herpesvirus ORF45 and the viral protein kinase ORF36. J. Virol. 90, 5953–5964 (2016).
pubmed: 27099309 pmcid: 4907238 doi: 10.1128/JVI.00516-16
Uetz, P. et al. Herpesviral protein networks and their interaction with the human proteome. Science 311, 239–242 (2006).
pubmed: 16339411 doi: 10.1126/science.1116804
Calderwood, M. A. et al. Epstein–Barr virus and virus human protein interaction maps. Proc. Natl Acad. Sci. USA 104, 7606–7611 (2007).
pubmed: 17446270 doi: 10.1073/pnas.0702332104
Li, R. et al. Phosphoproteomic profiling reveals Epstein–Barr virus protein kinase integration of DNA damage response and mitotic signaling. PLoS Pathog. 11, e1005346 (2015).
pubmed: 26714015 pmcid: 4699913 doi: 10.1371/journal.ppat.1005346
Umaña, A. C., Iwahori, S. & Kalejta, R. F. Direct substrate identification with an analog sensitive (AS) VIral Cyclin-dependent Kinase (v-Cdk). ACS Chem. Biol. 13, 189–199 (2018).
pubmed: 29215867 doi: 10.1021/acschembio.7b00972
Iwahori, S., Umaña, A. C., VanDeusen, H. R. & Kalejta, R. F. Human cytomegalovirus-encoded viral cyclin-dependent kinase (v-CDK) UL97 phosphorylates and inactivates the retinoblastoma protein-related p107 and p130 proteins. J. Biol. Chem. 292, 6583–6599 (2017).
pubmed: 28289097 pmcid: 5399109 doi: 10.1074/jbc.M116.773150
Taipale, M. et al. Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. Cell 150, 987–1001 (2012).
pubmed: 22939624 pmcid: 3894786 doi: 10.1016/j.cell.2012.06.047
Sun, X. et al. Hsp90 inhibitor 17-DMAG decreases expression of conserved herpesvirus protein kinases and reduces virus production in Epstein-Barr virus-infected cells. J. Virol. 87, 10126–10138 (2013).
pubmed: 23843639 pmcid: 3754017 doi: 10.1128/JVI.01671-13
Schulman, B. A., Lindstrom, D. L. & Harlow, E. Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A. Proc. Natl Acad. Sci. USA 95, 10453–10458 (1998).
pubmed: 9724724 doi: 10.1073/pnas.95.18.10453
Isegawa, Y. et al. Characterization of the human herpesvirus 6 U69 gene product and identification of its nuclear localization signal. J. Virol. 82, 710–718 (2008).
pubmed: 18003734 doi: 10.1128/JVI.00736-07
Sorg, G. & Stamminger, T. Mapping of nuclear localization signals by simultaneous fusion to green fluorescent protein and to beta-galactosidase. Biotechniques 26, 858–862 (1999).
pubmed: 10337476 doi: 10.2144/99265bm12
Muranyi, W., Haas, J., Wagner, M., Krohne, G. & Koszinowski, U. H. Cytomegalovirus recruitment of cellular kinases to dissolve the nuclear lamina. Science 297, 854–857 (2002).
pubmed: 12161659 doi: 10.1126/science.1071506
Marceau, A. H. et al. Structural basis for LIN54 recognition of CHR elements in cell cycle-regulated promoters. Nat. Commun. 7, 12301 (2016).
pubmed: 27465258 pmcid: 4974476 doi: 10.1038/ncomms12301
Iwahori, S. & Kalejta, R. F. Phosphorylation of transcriptional regulators in the retinoblastoma protein pathway by UL97, the viral cyclin-dependent kinase encoded by human cytomegalovirus. Virology 512, 95–103 (2017).
pubmed: 28946006 pmcid: 5653418 doi: 10.1016/j.virol.2017.09.009
Girard, F., Strausfeld, U., Fernandez, A. & Lamb, N. J. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell 67, 1169–1179 (1991).
pubmed: 1836977 doi: 10.1016/0092-8674(91)90293-8
Cardoso, M. C., Leonhardt, H. & Nadal-Ginard, B. Reversal of terminal differentiation and control of DNA replication: cyclin A and Cdk2 specifically localize at subnuclear sites of DNA replication. Cell 74, 979–992 (1993).
pubmed: 8402887 doi: 10.1016/0092-8674(93)90721-2
Maridor, G., Gallant, P., Golsteyn, R. & Nigg, E. A. Nuclear localization of vertebrate cyclin A correlates with its ability to form complexes with cdk catalytic subunits. J. Cell Sci. 106, 535–544 (1993).
pubmed: 8282760
Wiebusch, L., Neuwirth, A., Grabenhenrich, L., Voigt, S. & Hagemeier, C. Cell cycle-independent expression of immediate-early gene 3 results in G1 and G2 arrest in murine cytomegalovirus-infected cells. J. Virol. 82, 10188–10198 (2008).
pubmed: 18667506 pmcid: 2566281 doi: 10.1128/JVI.01212-08
Wagner, M. et al. Comparison between human cytomegalovirus pUL97 and murine cytomegalovirus (MCMV) pM97 expressed by MCMV and vaccinia virus: pM97 does not confer ganciclovir sensitivity. J. Virol. 74, 10729–10736 (2000).
pubmed: 11044117 pmcid: 110947 doi: 10.1128/JVI.74.22.10729-10736.2000
Adams, P. D. et al. Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors. Mol. Cell. Biol. 16, 6623–6633 (1996).
pubmed: 8943316 pmcid: 231664 doi: 10.1128/MCB.16.12.6623
Eifler, M. et al. PUL21a-Cyclin A2 interaction is required to protect human cytomegalovirus-infected cells from the deleterious consequences of mitotic entry. PLoS Pathog. 10, e1004514 (2014).
pubmed: 25393019 pmcid: 4231158 doi: 10.1371/journal.ppat.1004514
Caffarelli, N., Fehr, A. R. & Yu, D. Cyclin A degradation by primate cytomegalovirus protein pUL21a counters its innate restriction of virus replication. PLoS Pathog. 9, e1003825 (2013).
pubmed: 24385906 pmcid: 3873445 doi: 10.1371/journal.ppat.1003825
Webel, R. et al. Nuclear import of isoforms of the cytomegalovirus kinase pUL97 is mediated by differential activity of NLS1 and NLS2 both acting through classical importin-α binding. J. Gen. Virol. 93, 1756–1768 (2012).
pubmed: 22552943 doi: 10.1099/vir.0.040592-0
Chemes, L. B., de Prat-Gay, G. & Sánchez, I. E. Convergent evolution and mimicry of protein linear motifs in host-pathogen interactions. Curr. Opin. Struct. Biol. 32, 91–101 (2015).
pubmed: 25863584 doi: 10.1016/j.sbi.2015.03.004
Davey, N. E., Travé, G. & Gibson, T. J. How viruses hijack cell regulation. Trends Biochem. Sci. 36, 159–169 (2011).
pubmed: 21146412 doi: 10.1016/j.tibs.2010.10.002
Lange, A. et al. Classical nuclear localization signals: definition, function, and interaction with importin alpha. J. Biol. Chem. 282, 5101–5105 (2007).
pubmed: 17170104 doi: 10.1074/jbc.R600026200
Christie, M. et al. Structural biology and regulation of protein import into the nucleus. J. Mol. Biol. 428, 2060–2090 (2016).
pubmed: 26523678 doi: 10.1016/j.jmb.2015.10.023
Zacksenhaus, E., Bremner, R., Phillips, R. A. & Gallie, B. L. A bipartite nuclear localization signal in the retinoblastoma gene product and its importance for biological activity. Mol. Cell. Biol. 13, 4588–4599 (1993).
pubmed: 8336704 pmcid: 360081 doi: 10.1128/MCB.13.8.4588
Adams, P. D. et al. Retinoblastoma protein contains a C-terminal motif that targets it for phosphorylation by cyclin-cdk complexes. Mol. Cell. Biol. 19, 1068–1080 (1999).
pubmed: 9891042 pmcid: 116037 doi: 10.1128/MCB.19.2.1068
Rodrı́guez-Vilarrupla, A. et al. Identification of the nuclear localization signal of p21cip1 and consequences of its mutation on cell proliferation. FEBS Lett. 531, 319–323 (2002).
pubmed: 12417334 doi: 10.1016/S0014-5793(02)03549-4
Krek, W. et al. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell 78, 161–172 (1994).
pubmed: 8033208 doi: 10.1016/0092-8674(94)90582-7
Müller, H. et al. Induction of S-phase entry by E2F transcription factors depends on their nuclear localization. Mol. Cell. Biol. 17, 5508–5520 (1997).
pubmed: 9271426 pmcid: 232399 doi: 10.1128/MCB.17.9.5508
Sugimoto, N. et al. Cdt1 phosphorylation by cyclin A-dependent kinases negatively regulates its function without affecting geminin binding. J. Biol. Chem. 279, 19691–19697 (2004).
pubmed: 14993212 doi: 10.1074/jbc.M313175200
Nishitani, H., Lygerou, Z. & Nishimoto, T. Proteolysis of DNA replication licensing factor Cdt1 in S-phase is performed independently of geminin through its N-terminal region. J. Biol. Chem. 279, 30807–30816 (2004).
pubmed: 15138268 doi: 10.1074/jbc.M312644200
Jiao, W. et al. Aberrant nucleocytoplasmic localization of the retinoblastoma tumor suppressor protein in human cancer correlates with moderate/poor tumor differentiation. Oncogene 27, 3156–3164 (2008).
pubmed: 18071317 doi: 10.1038/sj.onc.1210970
Coqueret, O. New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol. 13, 65–70 (2003).
pubmed: 12559756 doi: 10.1016/S0962-8924(02)00043-0
Petersen, B. O., Lukas, J., Sørensen, C. S., Bartek, J. & Helin, K. Phosphorylation of mammalian CDC6 by cyclin A/CDK2 regulates its subcellular localization. EMBO J. 18, 396–410 (1999).
pubmed: 9889196 pmcid: 1171134 doi: 10.1093/emboj/18.2.396
Rauwel, B. et al. Release of human cytomegalovirus from latency by a KAP1/TRIM28 phosphorylation switch. eLife 4, e06068 (2015).
pmcid: 4384640 doi: 10.7554/eLife.06068
Svrlanska, A. et al. A noncanonical function of polycomb repressive complexes promotes human cytomegalovirus lytic DNA replication and serves as a novel cellular target for antiviral intervention. J. Virol. 93, e02143–18 (2019).
pubmed: 30814291 pmcid: 6475799 doi: 10.1128/JVI.02143-18
Rai, T. S. et al. Histone chaperone HIRA deposits histone H3.3 onto foreign viral DNA and contributes to anti-viral intrinsic immunity. Nucleic Acids Res. 45, 11673–11683 (2017).
pubmed: 28981850 pmcid: 5691367 doi: 10.1093/nar/gkx771
Jordan, S. et al. Virus progeny of murine cytomegalovirus bacterial artificial chromosome pSM3fr show reduced growth in salivary Glands due to a fixed mutation of MCK-2. J. Virol. 85, 10346–10353 (2011).
pubmed: 21813614 pmcid: 3196435 doi: 10.1128/JVI.00545-11
Tischer, B. K., Smith, G. A. & Osterrieder, N. En passant mutagenesis: a two step markerless red recombination system. Methods Mol. Biol. 634, 421–430 (2010).
pubmed: 20677001 doi: 10.1007/978-1-60761-652-8_30
Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367–1372 (2008).
pubmed: 19029910 pmcid: 19029910 doi: 10.1038/nbt.1511
Tyanova, S. et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat. Methods 13, 731–740 (2016).
doi: 10.1038/nmeth.3901
Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523 (2019).
pubmed: 30944313 pmcid: 6447622 doi: 10.1038/s41467-019-09234-6

Auteurs

Boris Bogdanow (B)

Research group "Proteome Dynamics", Max Delbrück Center for Molecular Medicine, 13125, Berlin, Germany.
Research group "Structural Interactomics", Leibniz Forschungsinstitut für Molekulare Pharmakologie, 13125, Berlin, Germany.

Max Schmidt (M)

Labor für Pädiatrische Molekularbiologie, Charité Universitätsmedizin Berlin, 13353, Berlin, Germany.
Medizinische Klinik m.S. Hämatologie, Onkologie und Tumorimmunologie, Charité Universitätsmedizin Berlin, 12200, Berlin, Germany.

Henry Weisbach (H)

Labor für Pädiatrische Molekularbiologie, Charité Universitätsmedizin Berlin, 13353, Berlin, Germany.
PenCef Pharma GmbH, 13509, Berlin, Germany.

Iris Gruska (I)

Labor für Pädiatrische Molekularbiologie, Charité Universitätsmedizin Berlin, 13353, Berlin, Germany.

Barbara Vetter (B)

Labor für Pädiatrische Molekularbiologie, Charité Universitätsmedizin Berlin, 13353, Berlin, Germany.

Koshi Imami (K)

Research group "Proteome Dynamics", Max Delbrück Center for Molecular Medicine, 13125, Berlin, Germany.
Laboratory of Molecular & Cellular BioAnalysis, Kyoto University, 606-8501, Kyoto, Japan.

Eleonore Ostermann (E)

Heinrich Pette Institute, Leibniz Institute for Experimental Virology, 20251, Hamburg, Germany.

Wolfram Brune (W)

Heinrich Pette Institute, Leibniz Institute for Experimental Virology, 20251, Hamburg, Germany.

Matthias Selbach (M)

Research group "Proteome Dynamics", Max Delbrück Center for Molecular Medicine, 13125, Berlin, Germany.
Charité-Universitätsmedizin Berlin, 10117, Berlin, Germany.

Christian Hagemeier (C)

Labor für Pädiatrische Molekularbiologie, Charité Universitätsmedizin Berlin, 13353, Berlin, Germany.

Lüder Wiebusch (L)

Labor für Pädiatrische Molekularbiologie, Charité Universitätsmedizin Berlin, 13353, Berlin, Germany. lueder.wiebusch@charite.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH